Kiplinger’s says, in it’s August 2011 issue, that J&J is one of 6 cash-rich stocks to buy now. They note that J&J shares “have mostly lagged the stock market since the March 2009 bottom.” And also point out that “One of J&J’s problems has been quality-control issues at its McNeil Consumer Healthcare unit that resulted in [...]
Continue reading about Johnson & Johnson–Blue Chip, Value or Sell
China is not alone in violating human rights. International Olympics Committee and world expectations were that their behavior would improve if the the Olympics came there. It doesn’t seem that way. Just as importantly to me is the fact that not a day goes by that one product or another imported from China must be [...]